Saudi Journal of Gastroenterology
Home About us Instructions Submission Subscribe Advertise Contact Login    Print this page  Email this page Small font sizeDefault font sizeIncrease font size 
Users Online: 1071 
This article has been cited by
1Estudio de correlación entre la concentración de antígeno de superficie y la carga viral del virus de la hepatitis B en una población negativa para el antígeno e
Gemma Solé Enrech,Alex Larruzea Ibarra,Núria Busquets Carmona,Eugenio Berlanga Escalera
Revista del Laboratorio Clínico.2017;10(2)79
2Potential Applications of Serum HBsAg Level Measurement in Patients with Hepatitis B and D Co-Infection
Maria Belopolskaya
Gastroenterology & Hepatology: Open Access.2016;5(7)79
3The role of quantitative HBsAg in the natural history of e antigen-negative chronic hepatitis B: A Tunisian prospective study
Raoua Baklouti,Arwa Gueddiche,Mehdi Ben Abdelwahed,Firas Aissaoui,Majda Zakhama,Wided Bouhlel,Asma Sriha,Ikbel Kooli,Om Kalthoum Sallem,Aida Argoubi,Loghmeri Mohamed Hichem,Nabil Ben Chaabane,Leila Safer
Infectious Diseases Now.2021;51(5)464
4Serum HBeAg and HBV DNA levels are not always proportional and only high levels of HBeAg most likely correlate with high levels of HBV DNA
Ping Chen,Qinfen Xie,Xuan Lu,Chengbo Yu,Kaijin Xu,Bing Ruan,Hongcui Cao,Hainv Gao,Lanjuan Li
5Use of a Deep Learning Approach for the Sensitive Prediction of Hepatitis B Surface Antigen Levels in Inactive Carrier Patients
Hiroteru Kamimura,Hirofumi Nonaka,Masaya Mori,Taichi Kobayashi,Toru Setsu,Kenya Kamimura,Atsunori Tsuchiya,Shuji Terai
Journal of Clinical Medicine.2022;11(2)387
6Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers
Maria Pfefferkorn,Stephan Böhm,Tina Schott,Danilo Deichsel,Corinna M Bremer,Kathrin Schröder,Wolfram H Gerlich,Dieter Glebe,Thomas Berg,Florian van Bömmel
7Diagnostic strategy for occult hepatitis B virus infection and its clinical implications among patients at Upper Egypt
A.M. El-Adly,A.K. Meshaal,M.A. Mekky,H.F. Hetta,A.A. Wardany,A.A. El-Shanawany
Journal of Radiation Research and Applied Sciences.2020;13(1)440
8The role of quantitative HBsAg in patients with HBV DNA between 2000–20,000?IU/ml
Sibel Yildiz Kaya,Bilgül Mete,Abdurrahman Kaya,Ilker Inanç Balkan,Nese Saltoglu,Ömer Fehmi Tabak
Wiener klinische Wochenschrift.2021;133(13-14)647
9Hepatitis B inactive carriers: An overlooked population?
Inês Pita,Ana Maria Horta-Vale,Hélder Cardoso,Guilherme Macedo
GE Portuguese Journal of Gastroenterology.2014;21(6)241
10Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?
Shahnaz Sali,Heidar Sharafi,Seyede Hoda Alavian,Seyed Moayed Alavian,Faranak Etesam,Shima Salimi,Muayad A. Merza,Maryam Keshvari
Diagnostic Microbiology and Infectious Disease.2015;82(2)114
11Clinical Usefulness of HBsAg Quantification in Patients with Chronic Hepatitis B Infection
Ergenekon Karagoz,Alpaslan Tanoglu
Hepatitis Monthly.2017;17(4)114
12Analytical performance of three diagnostic reagents for HBsAg on an automatic ELISA analyzer
Jiayi Hou,Jianping Ren,Ling Song,Fen Zhao,Peijun Liang
Journal of Clinical Laboratory Analysis.2018;32(1)e22159
13Cytotoxic T lymphocytes and CD4 epitope mutations in the pre-core/core region of hepatitis B virus in chronic hepatitis B carriers in Northeast Iran
Sareh Zhand,Alijan Tabarraei,Amineh Nazari,Abdolvahab Moradi
Indian Journal of Gastroenterology.2017;36(4)253
14The correlation between serum HBsAg levels and viral loads depends upon wild-type and mutated HBV sequences rather than the HBeAg/anti-HBe status
Mo-Han Liu,Qin-Yan Chen,Tim J. Harrison,Guo-Jian Li,Hai Li,Xue-Yan Wang,Yu Ju,Jin-Ye Yang,Zhong-Liao Fang
Journal of Medical Virology.2015;87(8)1351
15Association of Mutations in the Basal Core Promoter and Pre-core Regions of the Hepatitis B Viral Genome and Longitudinal Changes in HBV Level in HBeAg Negative Individuals: Results From a Cohort Study in Northern Iran
Sima Besharat,Hossein Poustchi,Ashraf Mohamadkhani,Aezam Katoonizadeh,Abdolvahab Moradi,Gholamreza Roshandel,Neal David Freedman,Reza Malekzadeh
Hepatitis Monthly.2015;15(2)1351
16Consolidation period of 18 months no better at promoting off-treatment durability in HBeAg-positive chronic hepatitis B patients with tenofovir disoproxil fumarate treatment than a 12-month period
Chun-Hsiang Wang,Kuo-Kuan Chang,Ruey-Chang Lin,Ming-Jeng Kuo,Chi-Chieh Yang,Yuan-Tsung Tseng
  The Journal 
  Site Statistics 
  My Preferences 
  Online Submission 

Submit Articles


Join us